Transmission in Birmingham, UK, 2009-19: An Observational Study
Overview
Authors
Affiliations
Background: Over 10-years of whole-genome sequencing (WGS) of in Birmingham presents an opportunity to explore epidemiological trends and risk factors for transmission in new detail.
Methods: Between 1st January 2009 and 15th June 2019, we obtained the first WGS isolate from every patient resident in a postcode district covered by Birmingham's centralised tuberculosis service. Data on patients' sex, country of birth, social risk-factors, anatomical locus of disease, and strain lineage were collected. Poisson harmonic regression was used to assess seasonal variation in case load and a mixed-effects multivariable Cox proportionate hazards model was used to assess risk factors for a future case arising in clusters defined by a 5 single nucleotide polymorphism (SNP) threshold, and by 12 SNPs in a sensitivity analysis.
Findings: 511/1653 (31%) patients were genomically clustered with another. A seasonal variation in diagnoses was observed, peaking in spring, but only among clustered cases. Risk-factors for a future clustered case included UK-birth (aHR=2·03 (95%CI 1·35-3·04), < 0·001), infectious (pulmonary/laryngeal/miliary) tuberculosis (aHR=3·08 (95%CI 1·98-4·78), < 0·001), and lineage 3 (aHR=1·91 (95%CI 1·03-3·56), = 0·041) and 4 (aHR=2·27 (95%CI 1·21-4·26), = 0·011), vs. lineage 1. Similar results pertained to 12 SNP clusters, for which social risk-factors were also significant (aHR 1·72 (95%CI 1·02-2·93), = 0·044). There was marked heterogeneity in transmission patterns between postcode districts.
Interpretation: There is seasonal variation in the diagnosis of genomically clustered, but not non-clustered, cases. Risk factors for clustering include UK-birth, infectious forms of tuberculosis, and infection with lineage 3 or 4.
Funding: Wellcome Trust, MRC, UKHSA.
Understanding Mycobacterium tuberculosis through its genomic diversity and evolution.
Sweeney M, Carranza C, Tobin D PLoS Pathog. 2025; 21(2):e1012956.
PMID: 40019877 PMC: 11870338. DOI: 10.1371/journal.ppat.1012956.
Esteves L, Gomes L, Brites D, Fandinho F, Bhering M, Pereira M Antibiotics (Basel). 2024; 13(6).
PMID: 38927163 PMC: 11200758. DOI: 10.3390/antibiotics13060496.
Puyen Z, Santos-Lazaro D, Vigo A, Cotrina V, Ruiz-Nizama N, Alarcon M PLoS One. 2024; 19(6):e0304130.
PMID: 38861531 PMC: 11166294. DOI: 10.1371/journal.pone.0304130.
Liu D, Huang F, Li Y, Mao L, He W, Wu S Emerg Microbes Infect. 2024; 13(1):2348505.
PMID: 38686553 PMC: 11097701. DOI: 10.1080/22221751.2024.2348505.
The effect of M. tuberculosis lineage on clinical phenotype.
Du D, Geskus R, Zhao Y, Codecasa L, Cirillo D, van Crevel R PLOS Glob Public Health. 2023; 3(12):e0001788.
PMID: 38117783 PMC: 10732390. DOI: 10.1371/journal.pgph.0001788.